Hong Kong, January 12, 2022 The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to HKG epiTherapeutics Ltd Laboratory, Hong Kong, based on results of recent on-site inspection as part
HKG Epitherapeutics is pleased to announce that it has achieved compliance with the federally mandated standards of the Health Insurance Portability and Accountability Act (HIPAA) through the use of Compliancy Group’s proprietary HIPAA methodology, The
McGill researchers identify new markers for early detection of cervical cancer. While the mortality rate for cervical cancer has declined dramatically since the 1970s, more than 400 Canadian women succumbed to the disease in 2019.
HKG Epitherapeutics is on a mission to improve healthcare and well-being for people worldwide Hong Kong (Sept. 30, 2019) – HKG epiTherapeutics, a Hong Kong-based startup, has announced today the launch of their first product
